CLRB Fair Value
What is the fair value of CLRB?
As of 2025-05-16, the Fair Value of Cellectar Biosciences Inc (CLRB) is -4.84 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.25 USD, the upside of Cellectar Biosciences Inc is -2006.7%.
Is CLRB a good investment?
With the market price of 0.25 USD and our fair value calculation, Cellectar Biosciences Inc (CLRB) is not a good investment. Investing in CLRB stocks now will result in a potential loss of 2006.7%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 12-2020 | 12-2021 | 12-2022 | 12-2023 | 12-2024 | 5Y Avg | |
| Net income | -15.09 | -24.12 | -28.6 | -42.77 | -44.58 | -31 |
| YoY growth | -7.1% | -59.8% | -18.6% | -49.5% | -4.2% | -27.9% |
| Market Cap (mil) | EPS | Fair Value | Upside | ||
| a | |||||
Cellectar Biosciences Inc | 12 | -1 | -4.84 | -2006.7% | |
| Abbvie Inc | 321,388 | 2.4 | 19.45 | -89.3% | |
| Amgen Inc | 146,074 | 11 | 55.18 | -79.7% | |
| Regeneron Pharmaceuticals Inc | 63,161 | 41.7 | 1,041.8 | 78.1% | |
| Liminal BioSciences Inc | 28 | 0.1 | 0.51 | -94% | |
| PharmaCyte Biotech Inc | 7 | 3 | 58.82 | 5555.5% | |
| Market Cap (mil) | 12 |
| P/E | - |
| Forward P/E | - |
| EPS | -0.97 |
| Avg earnings growth rate | -27.9% |
| TTM earnings | -45 |
Peter Lynch is one of the most legendary investors/fund managers of all time. His philosophy for stock investing is very simple and straightforward: he invests in stocks that are undervalued, meaning its P/E is less than or equal to its earnings growth rate. He believes that if a stock is trading at its fair value, the PEG ratio, which was also invented by him, should be 1.
Therefore, his formula to determine a company's fair value is:
Peter Lynch Fair Value = Earnings Growth Rate * EPS * PEG
PEG is set to 1 so we can ignore it in the calculation. Based on the formula, if the earnings growth rate of a company is 15%, Peter Lynch is willing to buy its share up to P/E = 15.